Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Oleg Iliich Epshtein has 3 pending office actions in Biotechnology & Pharmaceuticals. The profile shows 3 distinct examiners and 3 distinct art units, with each matter following a separate examination assignment.
PALENIK, JEFFREY T is the busiest examiner, with 1 pending action. The data does not support a recurring examiner-specific issue, so each application should be evaluated on its own record. Counsel can retain consistent terminology across the portfolio while tailoring technical and claim arguments to each matter.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PALENIK, JEFFREY T | 1 | 53.5% | +27.1% |
| MILLER, CAMERON KENNETH | 1 | 81.7% | +0.5% |
| IANNUZO, NATALIE NMN | 1 | 11.9% | +71.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17608270 | MEDICAMENT AND METHOD FOR TREATING INFECTIOUS DISEASES | IANNUZO, NATALIE NMN | 98d overdue |
| 19034970 | Drug For Treating Disorders Of An Organ Or Tissue Function And Diseases Accompanied By Such Disorders, And The Method For Obtaining It | PALENIK, JEFFREY T | — |
| 18564792 | MODIFYING AGENT AND METHOD OF ALTERING THE ELECTROPHYSICAL AND MAGNETIC PROPERTIES OF A CERAMIC | MILLER, CAMERON KENNETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17608270 | MEDICAMENT AND METHOD FOR TREATING INFECTIOUS DISEASES | IANNUZO, NATALIE NMN | 98d overdue |
| 19034970 | Drug For Treating Disorders Of An Organ Or Tissue Function And Diseases Accompanied By Such Disorders, And The Method For Obtaining It | PALENIK, JEFFREY T | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| 1759 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19034970 | Drug For Treating Disorders Of An Organ Or Tissue Function And Diseases Accompanied By Such Disorders, And The Method For Obtaining It | PALENIK, JEFFREY T | 1615 | §103§112 | Non-Final OA | — | Pending | Jan 23, 2025 |
| 18564792 | MODIFYING AGENT AND METHOD OF ALTERING THE ELECTROPHYSICAL AND MAGNETIC PROPERTIES OF A CERAMIC | MILLER, CAMERON KENNETH | 1759 | §102§103§112 | Non-Final OA | — | Pending | Nov 28, 2023 |
| 17608270 | MEDICAMENT AND METHOD FOR TREATING INFECTIOUS DISEASES | IANNUZO, NATALIE NMN | 1653 | §101§103§112 | Final Rejection | 98d overdue | Pending | Nov 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOleg Iliich Epshtein has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.
Jeffrey T Palenik has the most, with 1 of Oleg Iliich Epshtein's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.